山河药辅
(300452)
| 流通市值：27.53亿 | | | 总市值：34.56亿 |
| 流通股本：1.87亿 | | | 总股本：2.34亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 241,451,250.08 | 184,674,669.46 | 221,148,297.23 | 192,690,005.5 |
| 交易性金融资产 | 486,869,632.46 | 523,010,381.07 | 475,107,347.9 | 515,633,361.74 |
| 应收票据及应收账款 | 193,148,269.14 | 178,741,208.89 | 206,188,618.12 | 151,185,929.75 |
| 其中：应收票据 | 37,707,356.92 | 44,668,504.91 | 47,474,529.09 | 44,920,193.97 |
| 应收账款 | 155,440,912.22 | 134,072,703.98 | 158,714,089.03 | 106,265,735.78 |
| 应收款项融资 | 43,331,121.82 | 49,330,708.59 | 46,735,501.29 | 53,544,169.81 |
| 预付款项 | 11,701,038.4 | 11,734,177.44 | 16,737,381.2 | 11,069,250.11 |
| 其他应收款合计 | 1,070,279.53 | 1,043,815.17 | 901,858.42 | 1,050,572.41 |
| 存货 | 81,879,129.8 | 88,827,407.64 | 81,234,134.67 | 88,758,572.74 |
| 其他流动资产 | 5,846,383.93 | 6,326,154.21 | 7,101,755.48 | 7,600,006.15 |
| 流动资产合计 | 1,065,297,105.16 | 1,043,688,522.47 | 1,055,154,894.31 | 1,021,531,868.21 |
| 非流动资产: | | | | |
| 固定资产 | 446,897,806.33 | 453,429,557.86 | 464,584,220.38 | 464,905,884.26 |
| 在建工程 | 42,308,236.44 | 31,703,775 | 4,675,551.18 | 11,543,011.58 |
| 无形资产 | 55,340,686.19 | 55,692,969.95 | 56,045,253.71 | 51,224,727.66 |
| 长期待摊费用 | 3,320,563.51 | 1,834,459.38 | 2,013,779.7 | 2,193,100.02 |
| 递延所得税资产 | 5,931,040.13 | 5,945,789.66 | 5,928,041.17 | 5,959,272.94 |
| 其他非流动资产 | 6,655,415.9 | 3,173,408.92 | 2,089,829.76 | 2,372,523.47 |
| 非流动资产合计 | 560,453,748.5 | 551,779,960.77 | 535,336,675.9 | 538,198,519.93 |
| 资产总计 | 1,625,750,853.66 | 1,595,468,483.24 | 1,590,491,570.21 | 1,559,730,388.14 |
| 流动负债: | | | | |
| 短期借款 | 4,838,145.3 | 6,514,884.2 | 15,297,999.2 | 6,461,053.06 |
| 应付票据及应付账款 | 187,381,891.19 | 193,885,619.67 | 159,648,552.85 | 186,088,782.6 |
| 其中：应付票据 | 121,600,745.9 | 113,287,619.3 | 106,832,457.3 | 108,641,087 |
| 应付账款 | 65,781,145.29 | 80,598,000.37 | 52,816,095.55 | 77,447,695.6 |
| 预收款项 | 91,035 | 88,875 | 118,305 | 108,405 |
| 合同负债 | 5,661,507.85 | 5,918,291.28 | 4,443,772.43 | 6,978,017 |
| 应付职工薪酬 | 8,147,307.67 | 8,024,731.44 | 7,959,569.07 | 14,861,514.57 |
| 应交税费 | 11,456,486.97 | 9,992,884.96 | 6,367,055.67 | 2,133,256.77 |
| 其他应付款合计 | 478,106.45 | 515,803 | 434,920.17 | 338,865.02 |
| 其他流动负债 | 14,472,652.33 | 16,932,014.01 | 19,488,675.38 | 16,504,886.28 |
| 流动负债合计 | 232,527,132.76 | 241,873,103.56 | 213,758,849.77 | 233,474,780.3 |
| 非流动负债: | | | | |
| 应付债券 | 306,653,557.45 | 304,103,406.49 | 301,352,710.26 | 298,514,925.63 |
| 递延收益 | 32,625,714.34 | 33,795,418.33 | 34,999,955.64 | 33,492,159.62 |
| 递延所得税负债 | 20,721,058.98 | 21,646,568.25 | 18,062,901.41 | 18,948,759.79 |
| 非流动负债合计 | 360,000,330.77 | 359,545,393.07 | 354,415,567.31 | 350,955,845.04 |
| 负债合计 | 592,527,463.53 | 601,418,496.63 | 568,174,417.08 | 584,430,625.34 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 234,449,862 | 234,449,487 | 234,448,828 | 234,448,462 |
| 其他权益工具 | 30,034,709.23 | 30,035,261.72 | 35,340,198.13 | 35,340,750.63 |
| 资本公积 | 65,526,757.19 | 65,521,835.22 | 65,513,020.9 | 65,508,162 |
| 减:库存股 | 22,505,816.02 | 22,505,816.02 | 22,505,816.02 | 22,505,816.02 |
| 专项储备 | 426,798.47 | 604,496 | 381,587.13 | 67,327.74 |
| 盈余公积 | 103,813,602.04 | 103,813,602.04 | 103,813,602.04 | 103,813,602.04 |
| 未分配利润 | 551,114,022.24 | 511,585,263.91 | 535,514,203.66 | 488,337,307.97 |
| 归属于母公司股东权益合计 | 962,859,935.15 | 923,504,129.87 | 952,505,623.84 | 905,009,796.36 |
| 少数股东权益 | 70,363,454.98 | 70,545,856.74 | 69,811,529.29 | 70,289,966.44 |
| 股东权益合计 | 1,033,223,390.13 | 994,049,986.61 | 1,022,317,153.13 | 975,299,762.8 |
| 负债和股东权益合计 | 1,625,750,853.66 | 1,595,468,483.24 | 1,590,491,570.21 | 1,559,730,388.14 |
| 公告日期 | 2025-10-21 | 2025-08-27 | 2025-04-23 | 2025-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |